Speaker – Professor Mark Nelson

Professor Mark Nelson

Cardiometabolic Health Update Session: Managing essential hypertension and CVD

Mark Nelson is Professor and Chair, Discipline of General Practice, and Senior Professorial Fellow, Menzies Institute for Medical Research, and an Adjunct Professor, Department of Epidemiology and Preventive Medicine, Monash University. He is Medical Director of the Blood Pressure Clinic, MIMR, and is also in general practice in Hobart. His research interests are around large-scale clinical trials of cardiovascular disease prevention in primary care.

Professor Nelson is a principal investigator on the ASPREE study, which investigated the effectiveness of aspirin as a preventative therapy. ASPREE is the largest clinical trial ever conducted in Australia. It began 17 years ago, involved nearly 20,000 participants and has received about $100 million in funding.

Following on from ASPREE, Professor Nelson is also a principal investigator for STAREE. This large-scale clinical trial will use the same methods to evaluate the benefits of taking statins – cholesterol-lowering agents – as a preventative strategy.